RecruitingNCT01763125
Establishment of a Tumor Bank for Blood Samples
Establishment of a Blood Sample Bank in the Field of Gynaecological Oncology.
Sponsor
Medical University of Vienna
Enrollment
10,000 participants
Start Date
Nov 1, 2003
Study Type
OBSERVATIONAL
Conditions
Summary
Establishment of a tumor bank, consisting of blood samples of tumor patients and healthy people as controls. The blood samples will be collected systematically together with the corresponding clinical data. The biological samples, the clinical date together with prospective experimental date constitute the entity of the tumor bank.
Eligibility
Min Age: 18 Years
Inclusion Criteria4
- Male/Female
- Age 18 to 90 years max.
- Just one current known malignant disease or
- Just one current inflammatory disease
Exclusion Criteria4
- Inflammatory disease and malignant disease
- multiple malignancies
- multiple diseases
- underage
Interventions
OTHERBlood collection
Blood sample is collected during routine blood collection by a medical doctor. No more than 60ml (max.) at one timepoint.
Locations(6)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT01763125
Related Trials
A Study of Disitamab Vedotin With Other Anticancer Drugs in Solid Tumors
NCT06157892139 locations
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
NCT04389632154 locations
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
NCT07060807149 locations
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
NCT06312176257 locations
Longitudinal Body Composition Assessment in Breast Cancer Patients
NCT074728031 location